[Progress in treatment of herpetic keratitis].
Uchida
Y
Y
Nakagawa
H
H
D003646:Debridement; D003907:Dexamethasone / Q000627:therapeutic use; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use*; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use*; D007635:Keratitis, Dendritic / Q000628:therapy*; D013936:Thymidine / Q000031:analogs & derivatives*; D014271:Trifluridine / Q000627:therapeutic use*; D014740:Vidarabine / Q000627:therapeutic use*
D003907:Dexamethasone; D007372:Interferons; D014740:Vidarabine; D007065:Idoxuridine; D014271:Trifluridine; D013936:Thymidine